Novel Therapeutics in Myelodysplastic SyndromesNovel Therapeutics in Myelodysplastic Syndromes
Ahmed Abdul Hameed Mohammad;
Abstract
Myelodysplastic syndromes (MDS) entails a series of hematologic conditions characterized by chronic cytopenias and abnormal cellular maturation. Although supportive treatment remains the main approach, advances in understanding pathogenesis of MDS have g
Other data
| Title | Novel Therapeutics in Myelodysplastic SyndromesNovel Therapeutics in Myelodysplastic Syndromes | Other Titles | بحث حول الأساليب العلاجية الحديثة لمتلازمة خلل النخاع | Authors | Ahmed Abdul Hameed Mohammad | Keywords | Novel Therapeutics in Myelodysplastic SyndromesNovel Therapeutics in Myelodysplastic Syndromes | Issue Date | 2010 | Description | Myelodysplastic syndromes (MDS) entails a series of hematologic conditions characterized by chronic cytopenias and abnormal cellular maturation. Although supportive treatment remains the main approach, advances in understanding pathogenesis of MDS have g |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.